Rethink Your People Strategy for a Recovering but Volatile Biopharma Market: Navigate Immigration Complexity, Build Commercial Readiness & Get Ahead of the Turnover Wave - With Peers Running the Same Race
Running a lean HR function inside a clinical-stage biopharma company is unlike anything else in the industry. HR leaders are making decisions that affect drug development timelines, culture in the face of clinical failure, talent acquisition in a market where everyone is hiring the same rare disease specialists, and workforce planning with a cash runway measured in months. The playbooks from big pharma don't apply and the strategies from other industries don't translate. What HR leaders in emerging biopharma need is a room full of people who are and have been exactly where they are.
Join CHROs, Chief People Officers, Heads of HR, VPs of People, HR Directors, Talent Leaders & HR Business Partners from emerging and clinical-stage biopharma companies navigating growth, workforce transformation and market uncertainty. Benchmark your people strategy against peers facing the same funding pressures, talent challenges and commercialization milestones, while gaining practical insights you can implement immediately.
Now in its 6th edition, LEAP HR: Emerging Biopharma returns to Boston this December as the only event dedicated exclusively to the strategic people challenges facing HR leaders at emerging biopharma companies. Through practical case studies, benchmarking discussions, interactive roundtables and candid peer-to-peer networking, you'll learn how fellow HR leaders are navigating commercialization, retention, AI adoption, workforce planning and organizational growth in an increasingly complex market.
Leave with practical strategies, new peer connections and a clear action plan for building a resilient, future-ready workforce.
Among the Most Future-Focused C-Suite HR Leaders Sharing Case Studies in 2026
Attending Companies Include